Vanishing liver tumours

Clinical Radiology

Volumn 63, Issue 3, 2008, Pages 329-339

  Peddu, P ^a   Huang, D ^a   Kane, P A ^a   Karani, J B ^a   Knisely, A S ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN TUMOR; CANCER REGRESSION; DIFFERENTIAL DIAGNOSIS; HUMAN; LIVER TUMOR; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; REVIEW; TUMOR DIAGNOSIS;

ADENOMA, LIVER CELL; ADULT; AGED; BILIARY TRACT DISEASES; CARCINOMA, HEPATOCELLULAR; FEMALE; GRANULOMA, PLASMA CELL; HEMANGIOENDOTHELIOMA; HUMANS; INFANT; INFANT, NEWBORN; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM REGRESSION, SPONTANEOUS; TOMOGRAPHY, SPIRAL COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 38949164778     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2007.08.009     Document Type: Review

References (43)

1. Weinberg A.G., and Finegold M.J. Primary hepatic tumors of childhood. Hum Pathol 14 (1983) 512-537
2. Selby D.M., Stocker J.T., and Ishak K.G. Angiosarcoma of the liver in childhood: a clinicopathologic and follow-up study of 10 cases. Pediatr Pathol 12 (1992) 485-498
3. Chandra R.S., and Stocker J.T. The liver, gallbladder, and biliary tree. In: Stocker J.T., and Dehner L.P. (Eds). Pediatric pathology (1992), Lippincott, Philadelphia, PA 703-789
4. Keslar P.J., Buck J.L., and Selby D.N. Infantile hemangioendothelioma of the liver revisited. RadioGraphics 13 (1993) 657-670
5. Lucaya J., Enriquez G., Amat L., et al. Computed tomography of infantile hepatic hemangioendothelioma. AJR Am J Roentgenol 144 (1985) 821-826
6. Stanley P., Geer G.D., Miller J.H., et al. Infantile hepatic hemangiomas: clinical features, radiological investigation, and treatment of 20 patients. Cancer 64 (1989) 936-949
7. Edmondson H.A. Atlas of tumor pathology: tumors of the liver and intrahepatic bile ducts, fasc 25 (1958), Armed Forces Institute of Pathology, Washington, DC
8. Wanless I., and Medline A. Role of estrogens as promoters of hepatic neoplasia. Lab Invest 46 (1982) 313-320
9. Soe K.L., Soe M., and Gluud S. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 12 (1992) 73-79
10. Grazioli L., Federle M.P., Brancatelli G., et al. Hepatic adenomas: imaging and pathologic findings. RadioGraphics 21 (2001) 877-894
11. Talente G., Coleman R., Alter C., et al. Glycogen storage disease in adults. Ann Intern Med 120 (1994) 218-226
12. Golli M., Van Nhieu J.T., Mathieu D., et al. Hepatocellular adenoma: color Doppler US and pathologic correlations. Radiology 190 (1994) 741-744
13. Chung K.Y., Mayo-Smith W.W., Saini S., et al. Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 165 (1995) 303-308
14. Steinbrecher U.P., Lisbona R., Huang S.N., et al. Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci 26 (1981) 1045-1050
15. Ramseur W.L., and Cooper M.R. Asymptomatic liver cell adenomas: another case of resolution after discontinuation of oral contraceptive use. JAMA 239 (1978) 1647-1648
16. Edmondson H.A., Reynolds T.B., Henderson B., et al. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 86 (1977) 180-182
17. Leese T., Farges O., and Bismuth H. Liver cell adenomas: a 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 208 (1988) 558-564
18. Ault G.T., Wren S.M., Ralls P.W., et al. Selective management of hepatic adenomas. Am Surg 62 (1996) 825-829
19. Clark H.P., Carson W.F., Kavanagh P.V., et al. Staging and current treatment of hepatocellular carcinoma. RadioGraphics 25 Suppl. 1 (2005) S3-S23
20. Ulmer S.C. Hepatocellular carcinoma: a concise guide to its status and management. Postgrad Med 107 (2000) 117-124
21. Ayres R.C.S., Robertson D.A.F., Dewbery K.C., et al. Spontaneous regression of hepatocellular cancer. Gut 31 (1990) 722-724
22. Tilg H., Wilmer A., Vogel W., et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 103 (1992) 264-274
23. Ohba K., Omagari K., Nakamura T., et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastases. Gut 43 (1998) 575-577
24. Abiru S., Kato Y., Hamasaki K., et al. Spontaneous regression of hepatocellular carcinoma associated with elevated level of interleukin 18. Am J Gastroenterol 97 (2002) 774-775
25. Gottfried E.B., Steller R., Paronetto F., et al. Spontaneous regression of hepatocellular carcinoma: a case study. Gastroenterology 82 (1982) 770-774
26. Stoelben E., Koch M., Hanke S., et al. Spontaneous regression of hepatocellular carcinoma confirmed by surgical specimen: a report of two cases and review of the literature. Langenbecks Arch Surg 383 (1998) 447-452
27. Johnson F.L., Lerner K.G., Siegel M., et al. Association of anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 2 (1972) 1273-1276
28. Tocci G., Conte A., Guarascio P., et al. Spontaneous remission of hepatocellular carcinoma after massive gastrointestinal haemorrhage. Br Med J 300 (1990) 641-642
29. Markovic S., Ferlan-Marlot V., and Hlebanja Z. Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol 91 (1996) 392-393
30. Takayasu K., Muramatsu Y., Shima Y., et al. Necrosis of hepatocellular carcinoma as a result of subintimal injury occurred by hepatic angiography: report of two cases. Am J Gastroenterol 81 (1986) 979-983
31. Grossman M., Hoermann R., Weiss M., et al. Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol 90 (1995) 1500-1503
32. Umiker W.O., and Iverson L. Post inflammatory tumors of the lung: report of four cases simulating xanthoma, fibroma, or plasma cell tumor. J Thorac Surg 28 (1954) 55-62
33. Narla L.D., Newman B., Spottswood S.S., et al. Inflammatory pseudotumor. RadioGraphics 23 (2003) 719-729
34. Coffin C.M., Patel A., Perkins S., et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 14 (2001) 569-576
35. Cools J., Wlodarska I., Somers R., et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 34 (2002) 354-362
36. Sanders B.M., West K.W., Gingalewski C., et al. Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience. J Pediatr Surg 36 (2001) 169-173
37. Stark P., Sandbank J.C., Rudnicki C., et al. Inflammatory pseudotumor of the heart with vasculitis and venous thrombosis. Chest 102 (1992) 1884-1885
38. Dehner L.P. The enigmatic inflammatory pseudotumours: the current state of our understanding, or misunderstanding. J Pathol 192 (2000) 277-279
39. Levy S., Sauvanet A., Diebold M., et al. Spontaneous regression of an inflammatory pseudotumor of the liver presenting as an obstructing malignant biliary tumor. Gastrointest Endosc 53 (2001) 371-374
40. Torzilli G., Inoue K., Midorikawa Y., et al. Inflammatory pseudotumors of the liver: prevalence and clinical impact in surgical patients. Hepatogastroenterology 48 (2001) 1118-1123
41. Kim Y.W., Lee J.G., Kim K.S., et al. Inflammatory pseudotumor of the liver treated by hepatic resection: a case report. Yonsei Med J 47 (2006) 140-143
42. Koea J.B., Broadhurst G.W., Rodgers M.S., et al. Inflammatory pseudotumor of the liver: demographics, diagnosis and the case for nonoperative management. J Am Coll Surg 196 (2003) 226-235
43. Kaneko K., Ando H., Watanabe Y., et al. Aggressive preoperative management and extended surgery for inflammatory pseudotumor involving the hepatic hilum in a child. Surgery 129 (2001) 757-760